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Abstract 
同jJLTi五canti-tumor cellular immunity was川町？世dwith indirect macrophage migration 
inhibition tcヘtand ¥¥'inn a~say. .'¥on sp引 ificlymphoproliferative responses to mitogens were 
also studied. In the mice bearing :-i( :42 tumor‘speci五cin vivo anti-tumor immunity was elicited 
at early stage of tumor growth, when the spleen celb showed positive macrophage migration 
factor （九!IF)activity. The lymphoproliferative responses of the spleen cells were suppressed目
Removal of tumor not only recovered these引1ppressedimmunities but also gave tumor neu-
tralizing activity to the中leencells in ¥¥'inn assay. Passage through glass wool column restored 
lymphoproliferatin' response, of tumor-bearing spleen celb to normal spleen cell level. Their 
¥I IF activity became positivぞ afterthis treatment. The、pleencelb of the mice bearing large 
tumor suppressed lymphoproliferativl' response、ofnormal spleen cell、inco culture assay目
In contrast, they did not suppre出 edpositive ¥!IF activityア oftumor-removed spleen rels when 
they were co-culturl'd. These results suggested that there would be different immunosuppression 
on specific anti tumor immunityはndnon-sp引、：ificlymphoprol ifrrati＼で respon-;esto mitogcns in 
tumor bearing miCL' 
Introduction 
It is widely accepted that immunity of tumor-bearing ho叫 deteriorates出 atumor grows"6'81・ 
The mechanism of this cll'terioration has been proposed by many investigator,;. It was reported 
th乱tscra from canr・c・r patients blocked 日・II-mediatedtumor immunity101. There were many 
investigations which showed the suppre州 in・ effect討 oflymphocytes on either specific or non・ 
speci五Cimmunity"'・321 Ithむ beenrl'portecl that macrophage plays a ro!t、inthe suppression of 
cellular immunity of tumor-bearing ho山内1川 The relationship between the"e different mecha-
nisms of ,;uppreso.ion in a certain tumor-host system is important in the 円 aluationof immune 
Kεy以内rel、 ¥I《tcrophagemigrati<>n inhibition factor (¥I IF), ¥'in 出向川町 Lymphoproliferativeresponse, Tumor 
1mmumty, lmmunosuppress10n 
索引語：マクロファージ遊走阻止因I.腫場中向試験， リンパ球幼：｛＇f化反応，腫均免1乞免疫抑制．
Pre町ntaddress: The Sc、condI kpartment叶 Sur山 ry,Facultv of ¥!eclicine. Kyoto Universitv. 54 Kawara-cho、
日hogoin,Sakyo・ku, K、。to,606, Japan. 
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status of tumor bearing hosb and cancer immunotherapy. In this report, immunosuppression 
on specific anti tumor immunity of murine spleen cells assayed by macrophage migration inhi-
bition test and on their non-specific lymphoproliferative respon、（明 tomitogens following tumor 
growth and removal of tumor were、tudied.
Materials and Methods 
Mice and tumor. 
All experimentメ wereperformed with 6 to 10 week-old male DS mice which had been 
established as syngeneic mice from dd mice36> and kindly offered by the Aburabi Laboratories 
of Shionogi Pharm. Co. Shiga、Japan. Shionogi carcinoma 42 （日C42)22>,spontaneous mammary 
carcinoma of DS mice, was obtained from Dr. Kenji Yamaguchi、Instituteof S｝巾nogiPharm. 
Co目‘ Osaka、Japanand maintained by serial passages in DS male mice. 
Transplantation and removal of tumor. 
Tumor masses were minced and treated with 0.25% trypsin (Difco) in phosphate buffered 
saline (PBS) for 10 min at 37°C. Single cel suspension wa' obtained by passage through 
cotton gauge. These tumor cel suspension had a viability of 85 to 95% measured by trypan 
blue dye exclusion. The cel suspension containing 2×105 or 1×106 viable cells was injected 
into the footpad of hindleg. The thickness of footpad was measured periodically as tumor size, 
or tumor weight was measured by weighing the amputated legs. Removal of tumor was per 
formed by amputation of hindleg with tumor below the knee. 
Spleen cel preparation and partial removal of glass adherent cels. 
Spleens were obtained aseptically, minced and passed through UOO stainless mesh. The 
spleens from five mice of one group were pooled in MIF assay, Winn assay and lymphoprolifer-
ative response assay. Erythrocytes were ruptured by incubation with 0.83% NH4CJ in Tris 
buffer for 3 min at 37°C. Cell debris and clumps were allowed to settle by gravity for 5 min. 
The dissociated cells were washed with Hanks’balanced 'alt solution (HESS) and viability was 
measured with trypan blue dye exclusion. They had a viability of more than 90%. 
Glass wool was packed into 10 ml glass syringe and autoclaved. The glass wool column 
was washed with HESS and RPJ¥Il1640 supplemented with 10% fetal calf serum (FCS. ;¥[icro 
Biomedi仁s). The spleen cells suspended in RP:¥! I 1640 with 10% FCS were applied to the 
columns and washed out with the same medium. The percentage of peroxidase positive cells 
decreased from 7.4% to 6.7% in normal spleen cel、from12.2% to 6.5° 0 in tumor-removed spleen 
cel and from 21.1 % to 16.2% in tumor-bearing spleen cel. 
Antigen. 
The solubilization of tumor extract wa' performed by ultrasonication with the method of 
Haughton9J which was applied to H-2 antigen solubilization. The tumor cells were suspended 
in HB同 andcel concentration was adjusted to 1×lOB/ml. The ultrasonic cel breakage was 
performed for 90州、 withan ultrasonic disruptor (Tomyメeiko). The supernatant after centri-
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fugation 10、000rpm for 60 min was sterilized by filtration through 0.45 μ, 1¥l ilipore filter. The 
protein co郎、entrationwa' determined by Lowry’s method18> and adjusted to 10 mg/ml. The 
,upernatant wa討storedはt 20 （‘ until use. 
Winn assay. 
In vivoり・totoxicability of thl白中leencells was asse州巴dby Winn assay35> Twenty million 
of the ,pJeen cclls mixed with 2×10s of the tumor cel吋 wercinoculated in footpad of normal 
D:-; mice. Whethc届rthe tumor cells wer巳rじje孟ctedor not wa討 determined負veW正＇l邑
oculation. 
Indirect macrophage migration inhibition te札
a) Fir、tculturc: Spleen cells were川 spendedin RP 'VII 1640 supplemented with 100 μ,g/ml 
of gentamycin and adjusted to l×107 /ml. One ml of spleen cel suspension was i町 ubat巴dwith 
or without 0.1 ml of the antigen in 5%ぐ（）宮 inair at 37＜、 for24 hr. The spleen cel suspension 
incubated without antigen was suppkml'llted with 0.1 ml of the antigen at the end of incubation 
as control. Thl'y were centrifuged at 3,000 rpm for 20 min and the supげ natantswere stored at 
-20°（、untilsecond culture. 
b) メ刊のndculture: The agarose droplet mcthod described by Harrington7l was used in 
this a川町・ The peritoneal exudate cells (PL＜‘） of normal l >:-;mice induced by mineral oil 
(Bayol F, Wako Pure Chemical Indust.) wnc packed in 0.2% agarose (:-;ca Plaque Agarose, 
¥Tarim・ Colloids). Two microliter of agarose droplet was placed at the bottom of each well of 
Micro T引 tplateI (:¥ unc) by the microdispenser. After the settling down of the droplets. 
0.1 ml of supernatants of first culture supplemented with 10%円、お waspoured into each wel 
and incubated for 24 hrs at 37°C in 5% C< >2 in air. Then they were photographed under 
micro川・ope.
The distance of migration of PE<・ from the edge of the agarose droplet in four directions 
W出 measured. As討aywa' quadoplic‘ated and migration index (¥!I) was calculated as folows. 
mean distance of migration of PEC 
\ll=i空中里型Ee！~a~a_n!_l'.1日！t竺竺c!_.丸、h_t!:i己 antigen 一×100
mean distance of migration of PEC 
in the supernatant cultured without the antign<' 
Less than 86 was regardedはhpositive. 
Lymphoproliferative responsれ tomitogens 
The spleen cells we・resu,1wnded in RP¥1 [ 1640川tppkmcnteclwith 10% F< ・:-; at cel con-
ぽ ntrationof 5×106/ml. A 0.2 ml aliquot of the cel -;uspen叶onwas irn、ubateclin a wel of 
¥1 icro Tcstplate I with or without a mitogen. As mitogens （、onA ( ¥Vako Pure Chemical 
Indust.) and LP:-; (Difeo) were added 1 μ,g/well and 10 μg/well, respectively目 Theplates were 
incubated for 48 hrs at 37°（‘ in 5% ('();in air and then、0.25μ（、lof 3H thymidine (:¥ ew England 
:¥ uclcar）日出 addedto each well. After 17 hr incubation the ＜‘l' 1討 wereha rvcstccl with Cel 
Harvester (l¥lark I, ¥Vakcnyaku) and 3H-thymidine uptake was measured with a liquid scinti-
lation counter (J:-;UCAP 300, :¥ Uぐ！carChicago). 人柄aywas triplicated and lymphoproliferativc 
responses to mito宮町1メ1・nt・ assessed as follows 
199 I¥L¥ICN<lSl'PPRESSIO'.'¥ I:¥ Tlマ九IOR-BEARI~ ＜； ¥IIC'E 
Llcpm=cpm with mitogen-cpm without mitogen 
ト.；tatisticalanalysis. 
The x包 testwa' used to evaluate the significance of di仔erence有1>l"t¥¥"l'℃n groups in in vivo 
anti tumor immunity and Winn assay. 
Results 
Macrophage migration inhibition factor (MIF) activity of spleen cells following tumor growth 
and removal of tumor. 
The speci白ranti-tumor cellular immunity was assayed with an indirect macrophage mi 
gration inhibition test. About one week after transplantation of 1×106 SC・42tumor cells in 
footpad tumors became plapable. The spleen cel吋ofthe mice on day 7 showed positive ¥HF 
activity to the antigen solubilized by ultrasonication (Fig. 1). When tumors grew gradually, the 
spleen cels of the mice on day 14 stil had positive '.¥IF activity. As the tumors rapidly enlarged 
thereafter, the spleen cells on day 21 and day 28 lost positive ¥I IF activity. The spleen cells of 
the mice whose tumors had been removed on day 14 recovered positive '.¥IF activity on day 28. 
The normal spleen cells did not show positive ¥!IF activity to the antigen. 
Lymphoproliferative responses of spleen cells to mito伊nsfollowing tumor growth and removal 
of tumor. 
Lymphoproliferative responses of the tumor-bearing spleen cells to Con A and LPS had 
already decreased on day 7 after tumor cel transplantation, when their 1¥IIF activity became 
positive (Fig. 2). The response to Con A of spleen cells on day 14 decreased to half that of 
















Da" after Transplantation 
l¥IF activity of spleen cels following tumor growth and rL・mo、はIof tumor. l¥I 
les than 86 was regarded as positive ¥I IF activity. （・I¥I of tumor-bearing 
spleen cels, (O) MI of tumor-removed spleen cels and Ix) tumor weight目




































































































































































































activity wa' ,;til positive. When tumors grew rapidly thereafter and :¥!IF activity of the tumor-
bearing spleen cells became negativιtheir lymphoproliferative re、j)0:1吋日 toCon A on day 21 
and da v 28 were pre「erved. Removal of tumor on day 14 not only restored mitogen response 
to both ('on人andLPS hut al、orecovered l¥IIF activitv 
In vivo anti tumor immunity of mi川 followingtumor growth. 
In order to define in vivo anti-tumor immunity of tumor bearing mice, the mice were re-
challenged with tumor cclb on day 28 after tumors were removed on day 7, 14町 21or 28. The 
mire which received removal of tumor on day 7 or 14 rejected tumor cel rechallenge. On the 
other hand、thosewhich received it on day 21 or 28 allowed tumor growth (Table 1). This 
difference w師、tatぃticallysignificant (p<0.01). ¥¥'hen 2×10・1 of tumor cel宍weretransplanted, 
tumors grew more slowly and 4 of 7 mice whose tumors were removed on day 7 admitted the 
growth of rechallengerl. tumor cells.λ11 of the mice whose tumors were removed on day 14 or 
21 rejected rechallengcd tumors. These results sug宮町tedthat tumor transplantation elicited 
anti-tumor immunity in trはnsplantcdmire and that some tumor mass would be necessarv for the 
immunitv to beトtablishecl. ¥I oreover、largetumor日1ppr円、円lthis immunity. 
c¥nti-tumor activity of spleen celb in Winn ass品V
To elucidate competent immunity to r引いItumor cel r引・hallenge,Winn川出1y of spleen cels 
¥1・as performed. ( >1・ of nine mice to whi＜、hthe spleen凹 lsof tumor-removed mice were trans 
ferred with the tumor ＜、elsallowed tumor growth. :¥loメtof mice to which the spleen cels of the 
mi「ぞ bearing12.rge tumor or of normal mice W('f<' transferred with tumor cells allowed tumor 
I:¥I:¥IUN<>SUPPRESSIO:¥ IN Tl':-.IOR-BEARING :¥!ID 
Table 1. Anti-tumor Immunity of l¥lice Following Tumor Growth 
tumor cel removal of tumor tumor cel rejected/totald transplanta on dayt challengec 
1×10' 7 or 14 1×106 6/7• 
1×10' 21 or 28 1×106 0/7• 
l×106 1/5 
2×105 7 2×105 3/7 
2 xl05 14 2×10s 6/6 
2×10s 21 2×10s 4;4 
2×10s 2/6 
a: Tumor cels were transplanted into footpad of foreleg on day 0. b: Tumors 
were removed l1y amputation of foreleg. c: Tumor cels were challenged into fot-
pad of hindleg on day 28. d: The number of the mice rejected tumor cel cha!-
lenge was determined on dは，.56. e: PくO.Dl.
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growth (Table 2). The di百erencebetween tumor-removed spleen cells and normal spleen cells 
was statistically significant (p<0.01). This anti tumor activity of the spleen cells in Winn 剖 say
was well correlated with their MIF activity. 
Effect of removal of glass wool adherent cel日onMIF activity and lymphoproliferative responses. 
As tumors grew、spleenswere enlarged. Percentage of peroxidase positive cells in spleen 
cells increased following tumor growth. This suggested that non-lymphocytic cells were involved 
in the depression of MIF activity and lymphoproliferative responses of tumor-bearing spleen cells. 
The percentage of peroxidase positive cells in tumor bearing spleen cells was decreased after 
passage through glass wool column. While MIF activity of the whole spleen cells of the mice 
bearing large tumor was negative、theglass wool column passed cells of them showed positive 
'.¥!IF activity (Table 3). Both whole cells and glass wool column passed cells in the中leenof 
the mice bearing small tumor showed positive MIF activity. '.¥!either the whole cells nor the 
glass wool column passed cells in the normal spleen showed positive :¥IIF activity. Although 
'.¥IF activity of whole spleen cells of the tumor removed mice was positive, the cells passed 
through glass wool column lost the positive '.¥1IF activity. 
Lymphoproliferative responses of tumor bearing spleen cells to Con A were fully recovered 
by passage through the column and those to LPS were recovered partially. This treatment had 
litle effects on normal and tumor-removed spleen cell討（Table4). 














a: Tumor-removed spleen cels were obtained on day 28 from the mice whose tumors 
had been removed on day 14. Tumor司bearingspleen cels were from the mice on 
day 28 after tumor cel transplantation. b: The number of tumor r句ectedmice 
was＂同れ同 don day 35. c: pく0.01. d: p<0.05. 
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Table 3. E仔eelof J 'as＂‘ge through Glass ¥¥'ool仁olumnon ¥I IF Activ1,・ 
spleen cels 
¥!IF a川ivity(¥I I 



















































a: The spleen cels wne ol>tained from the mice on day 14 after tumor cel trans-
plantation. Li: the spleen cels from the mice on day 28. c: The 、pleencels ぃerι
from the mice on day 28 whり、ctumors were removed on d・り 14. d: ¥II le州 than 
86 "'"' wgarded as pmitiY1・ ¥IIFは什1～itv
Table 4. Effect of Pa出.t~ピ through Glass ¥¥'ool Columl on Lymphoproliferati、cR目P川1、t、
Con A LPS 
spleen Cl' li s• 
whole P川、じdb whole passedb 
normal 79584' 93088 38606 62810 
叫nailtumor-I川 ring 30235 74176 1789 19798 
large tumor-I削 ring 29813 93474 -374 13296 
tumor-removed 73706 51905 44027 45963 
a: Spleen celぉul'fじ＇＜ 1mc・ as Table 3. b: glass wool column passed 
cels. c Llcpm=cpm with mitogen－←cpm without mit . gen 
Suppressive activity of tumor-bearing spleen celb 
Recovery of i¥I IF activity and lymphoproliferativピrespon北対 bypassage through glass wool 
column suspected the existcn《1・ofsuppressor cels in tumor-bearing、pleencels. To certify this 
suspicion, co culture of spleen cels in vitro出刈ywa~ done. The spleen cels of the mice bearing 
large tumor ~uppressed lymphoproliferativc responses to both (:on A and LI市 ofthe normal 
斗》letncels co-cultured (Table 5). On the other hand, they did not suppreメSpositive ¥I IF 
activity of the tumor-removed spleen eelい（Table6). These results札1g炉、tcdthat mechanismョ
of suppn・引 onof spec1品canti-tumor immunity and nonspecific immunity might he di仇rent.
Table 5. E仔ectof Co・《・ulturewith Tumor-bearing SplじじnCels on 
Lymphoproliferative RL'sponses of ¥'ormal Spleen Cel、
spleen 仇・ll s• Con ,¥ LI・メ
norm泊I 65934h 47481 
tumor-bearing 15260 6115 
normal十tumor-!，山ring' 24111 18238 
a: Tumor-11山 ring叩lecncel' w1・n obtained from the mice on day 28 after tumor 
cel transplantation b: .:Jcpm=cpm with mltogen-cpm ¥thout m1togen. c 
¥ormal spl<Tn rじlsand tumor-hearing .splc1・n cels wn . mixed川 11 ratio. 
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Table 6. Efect of Co-culture with Tumor-Gearing Spleen Cels on 













a: Tumor-Gearing spleen cels were obtained from the mice on day 28 after tumor 
cel transplantation and tumor-removed spleen cels from those on day 28 whose 
tumors were removed on day 14. b: :¥I I les than 86 was regarded as positive I¥! IF 
activity. c: Co-culture was performed at 1: 1 ratio目
Discussion 
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:¥lat、rophagemigration inhibition test has been one of the reliable method討to出同州 cellular
immunities in vitro concerned with delayed type hypersensitivityL4·15•2B•30>. This method has 
also been applied to assay speci五canti-tumor immunity of tumor-bearing hosts and to detect 
tumor-speci命 antigens払20,29>. The tumor extract solubilized with frozen and thaw1的、 with
3 l¥I KCJI 7.21,31＞、 withN"onidet P-4023>, with papain19> and irradiated tumor cells33> were used 
as antigens for this assay. Cell extract solubilized with ultrasonication possessed H-2 antigen 
as measured by heamoagglutination inhibition9＞.日（‘ 42tumor cel extract solubilized with this 
method was used as an antigen for this assay assessing spec1日ranti-tumor immunity of murine 
spleen cels in this study. l¥IIF activity of the tumor bearing spleen cells became positive on day 
7 and 14 after tumor transplantation, while the normal spleen cells showed negative MIF activity. 
As the tumor grew rapidly thereafter, :¥I F activity of the spleen cells became negative. These 
results were also well correlated with in vivo anti-tumor immunity of the mice, that is司themice 
whose tumor removed on day 7 or 14 after tumor transplantation rejected tumor cel challenge, 
while those whose tumor removed on day 21 or 28 allowed tumor growth. This indicated that 
the tumor-bearing mice obtained specific anti-tumor activity as the tumor settled in the mice 
and as the tumor grew rapidly thereafter the mice lost the activity. and that the anti-tumor 
immunity would be assessed with macrophage migration inhibition test. 
Decrease of lymphoproliferative response in tumor-bearing hosts were reported by many 
investigators2•6•16> The lymphoproliferative response of the tumor-bearing spleen cells to Con A 
and LPメdecreasedfrom early stage of the tumor growth when the spleen cells showed positive 
:¥IIF activity (Figure 1 and 2). After removal of tumor, the lymphoproliferative respons巴 to
Con A and LPS reverted to the normal level. Positive :¥IIF activitv which would be lost with 
progressive tumor growth reappeared in tumor-removed spleen cels. :¥'foreover, theseぞels
possessed strong tumor neutralizing activity in Winn assay, while neither the spleen cells of large 
tumor bearer nor the normal spleen cells did. These results indicated that removal of tumor not 
only recovered nonspecific lymphoproliferative response to mitogens but also restored and 
strengthened speci五canti-tumor immunity，ぞonfirmingimmunological effectiveness of reduction 
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surgery in canぐげ thera.py.
1'.rRCH:¥ER et at.12> reported that、pleenfrom '.¥Joloney sarcoma virus tumor-hearing mire 
contained four time、thenumber of mononuclear E、elsand the decreased response to PHA of the旬
、plccncells restored by purifi仁川ionwith rayon column or by removal of phagocytic <db by an 
iron/magnet technique, and they川1ggcstedthat macrophage/monocyte series played a role in this 
immunosuppressive mechanism. PAIJARATHSl:¥<;H et al.24> also observed that esterase positive 
閃 I、orF c receptors p刷 itive('el、increasedin tumor－！祉はringspleen with progressive tumor 
growth川 dthat treatment of the・ぜ spleencells by pa川ingthrough ~l·phadはじ－ 10 columns or by 
in('ubation on plasti＜、 surfac引 toremove adher巴ntlTlls restored lymphoproliferative responses. 
~C 42 tumor-bearing spleen contained innca吐dperoxidase positive c・!lswith tumor growth目
Removal of glas,; adherent cells by passing through glass wool columns not only restored the 
lymphoproliferativc responses to mitogens but also recovered positive ¥HF activity (Table 3 and 
4). From these results it wa' suggested that in tumor bearing mice the glass adherent cels not 
only suppre討sednon-specifi＜、 lymphoprolifrrativen叶101;<'but a 1哨 regulated,;pecific anti tumor 
imロmnitv
（‘o-culture with the normal splccn 川 !lsconfirmed the immunosuppressive 礼ctivityof 
macrophage/monocytc series in tumor-! 川げingsplecm13·20•26•34> and the peripheral blood of 
cancer patients37>. In the present討tudy,the ,;pleen cell討 oflarge tumor bearer suppressed the 
lymphoproliferative response to ('on A and LPS of co cultured normal spleen cels, concur with 
the results of other investigators. On the other hand司 theydid not、uppre州 thepositive ¥I F 
.ictivity of the tumor-removed spleen cells when they were co cultured. The ;;upprcssivc mecha-
nisms of the、l川 i五canti-tumor immunity a州引町dwith macrophage migration inhibition test 
and its competent ('els are now under investigation川 ourlaboratory. ¥lorcovcr, the fact 
that though suppressed. the host bearing large tumor ,;til had specific川 titumor immunity would 
be a clue of specific immunotherapy for camγr patients. Our recent experiments showed that 
.,plcen t巴lbof small tumor lwarcr had weak tumor neutralizingはctivityin the Winn assay、which
was strengthened hy removal of plastic adherent cells. The anti tumorはctivityof these celb 
were augmi・nted by ('Ulture with the tumor extract solubilized with ultrasonirntion and these 
cells were proliferated by culture with T 円、Igrowth factor. When the,;c augmented and pro-
liferated cells were tramferred to the tumor bearing mice locally, they inhibited the tumor 
growthll>. 
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稲本 俊，菅 典道，大垣和久，日笠 頼則
同系の DS？ヴスと同系l屋湯川・1¥2を用いて， i屋
場増殖lとと もなう特異的抗腫蕩免疫能を牌細胞のマク
ロフ ァージ遊走阻止試験および腫蕩中和試験iιて検索
し，非特異的免疫能を各種 mitogenに対する幼若化
反応を用いて検索した．腫事.，）f事殖後早期lζ宿主は！匝場
抵抗性を獲得し，その牌細胞は腹場抗原lこ対するマク
ロフ ァー ジ遊走阻止因子活性陽性を示したー一方，幼
若化反応はとの時期から低下した， 腫霧ー が増殖するに
従って，これらのいずれの免疫能も抑制されたが，腫
場切除によりいずれも回復した．そして， l盛場切除を
ミけた牌細胞は腫煽中和試験において強い抗l屋場能を
示した．このことは，癌外科における reductionsur-
geryの腫蕩免疫の面からの意義が示されたと考えら
れる．腫癒を持った宿主の牌細胞の抑制された免疫能
はガラス線維カラムを通すととによりいずれも回復し
た．また，正常牌細胞と腫蕩を持った牌細胞を混合培
侍すると，正常牌細胞の幼若化反応は抑制されたが，
腫湯切除を受けた牌細胞のマクロファーシ遊走阻止因
子活性は腹携を持った牌細胞との混合培養によっても
抑制lを受けなかった．乙れらの乙とは腫務増殖にとも
なう特異的抗腫損害免疫能と非特異的免疫能とに対する
免疫抑制が質的に異っている乙とを示している．さら
に．特異的免疫能は臆務増殖により抑制されるものの
ガラス附着細胞を除くととにより回復させることがで
きる乙とから， 担1高宿主の自己のリンパ球から抗腫蕩
能を有するものを涜与し，特異的免疫療法を行うζと
ができる可能性を示唆している．
